Frontlight ResearchEarly access
Bladder cancer trials in Uganda
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in UgandaLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
- Where
- Kampala
- Age
- 18 years and over
- People
- 50
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07576725